By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Oncothyreon Inc. 

2601 Fourth Avenue
Suite 500
Seattle  Washington  98121   U.S.A.
Phone: 206-801-2100 Fax: 206-801-2101



Company News
Oncothyreon Inc. (ONTY) To Present At Upcoming Investor Conferences 2/17/2015 8:24:45 AM
Oncothyreon Inc. (ONTY) Announces Proposed Public Offerings 2/6/2015 7:45:56 AM
Oncothyreon Inc. (ONTY) Prices $22 Million Concurrent Public Offerings Of Common Stock And Preferred Stock 2/6/2015 7:36:14 AM
Adimab LLC. Announces New Partnerships With Acceleron Pharma, Oncothyreon Inc. (ONTY), Surface Oncology And Potenza 1/9/2015 9:48:23 AM
Oncothyreon Inc. (ONTY) Announces Presentation Of Positive ONT-380 Data At San Antonio Breast Cancer Symposium 12/12/2014 7:29:52 AM
Oncothyreon Inc. (ONTY) Strikes $300 Million Cancer Pact With Array BioPharma, Inc. (ARRY) 12/12/2014 7:26:54 AM
Oncothyreon Inc. (ONTY) To Present At Stifel 2014 Healthcare Conference 11/12/2014 10:27:11 AM
Oncothyreon Inc. (ONTY) And Celldex Therapeutics, Inc. (CLDX) Announce Initiation Of Combination Immunotherapy Clinical Trial Of ONT-10 And Varlilumab 11/11/2014 7:33:42 AM
Oncothyreon Inc. (ONTY) Reports Third Quarter 2014 Financial Results 11/7/2014 8:15:43 AM
Oncothyreon Inc. (ONTY) Announces Third Quarter 2014 Financial Results Conference Call 10/30/2014 8:43:11 AM